CarMax, Inc (KMX) Stock Price Today
Aura AI Summary
Key Stats
- $7.24BMarket Cap
- -Volume
- Consumer CyclicalSector
- $66.9452W High
- $30.8852W Low
- -Typical Hold Time
- $25.75BEnterprise Value
- -Div Yield
- -Trading Activity
Track CarMax, Inc (KMX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, CarMax, Inc has traded between a low of $30.88 and a high of $66.94, highlighting its annual price range. Buy and sell CarMax, Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About CarMax, Inc
CarMax sells, finances, and services used and new cars through a chain of over 230 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales typically account for about 83% of revenue and wholesale about 13%, with the remaining portion composed of extended service plans and repair. In fiscal 2022, the company retailed and wholesaled 924,338 and 706,212 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the U.S. but still estimates that it has only about 4% U.S. market share of vehicles 0-10 years old in 2021. It seeks over 5% share by the end of calendar 2025 and revenue between $33 billion to $45 billion by fiscal 2026. CarMax is based in Richmond, Virginia.
Most Recent News
Document AI market to nearly double to $27.62B by 2030, driven by AI and automation in regulated industries.
The Document AI market is forecasted to grow from $14.66 billion in 2025 to $27.62 billion by 2030, at a CAGR of 13.5%. This growth is fueled by organizations adopting AI technologies like intelligent document processing, generative AI, and workflow ...

AI in orthopedic surgery market to hit $0.87B by 2030 with 27.2% CAGR, driven by tech advances and rising musculoskeletal disorders
The AI in orthopedic surgery market is projected to grow from $0.26 billion in 2025 to $0.87 billion by 2030, at a CAGR of 27.2%. Growth is fueled by increased orthopedic surgeries, innovations in medical imaging, adoption of minimally invasive techn...

Generative AI in drug discovery market to reach $0.86B by 2030, growing at 27% CAGR driven by faster drug development and AI advances
The generative AI market in drug discovery is expanding rapidly, expected to grow from $0.33 billion in 2026 to $0.86 billion by 2030 with a 27% CAGR. Growth is fueled by rising drug development costs, advances in AI technologies like deep learning, ...
